---
layout: minimal-medicine
title: Indium (In 111) Imciromab Pentetate
---

# Indium (In 111) Imciromab Pentetate
### Generic Name
Indium (In 111) Imciromab Pentetate

### Usage
Indium (In 111) imciromab pentetate was a radiopharmaceutical used as a cardiac imaging agent. Its primary purpose was to detect myocardial injury, specifically to help diagnose myocardial infarction (heart attack).  It worked by targeting specific proteins released from damaged heart muscle cells.  This agent is no longer commercially available.

### Dosage
Because Indium (In 111) imciromab pentetate is no longer available, specific dosage information is not relevant.  Dosage would have been determined by a physician based on the individual patient's condition and weight, and administered via intravenous injection.  The amount of the radioisotope would have been carefully controlled to minimize radiation exposure while providing sufficient imaging quality.

### Side Effects
Since this medication is no longer in use, comprehensive side effect data is less readily available. However, potential side effects associated with this type of radiopharmaceutical could have included:

* Allergic reactions (rash, itching, swelling)
* Radiation exposure-related side effects (though usually minimal with appropriate dosage).


It's crucial to remember that any adverse effects, even if seemingly minor, should be reported to a medical professional immediately.  

### How it Works
Indium (In 111) imciromab pentetate utilizes a monoclonal antibody (imciromab) that specifically binds to myosin heavy chains.  These heavy chains are released into the bloodstream from damaged heart muscle cells during a heart attack. The Indium-111 isotope is a gamma emitter, allowing for its detection using a gamma camera to create an image of the heart. Areas of increased radioactivity indicated sites of myocardial injury.

### Precautions
As Indium (In 111) imciromab pentetate is no longer used, specific precautions are historical. However, general precautions for radiopharmaceuticals would have included:

* **Pregnancy and Breastfeeding:**  Use during pregnancy and breastfeeding would have been contraindicated due to radiation exposure risks to the fetus and infant.
* **Renal Impairment:**  Patients with kidney problems may have required dose adjustments or close monitoring due to potential issues with excretion of the radioactive material.
* **Allergic Reactions:**  Patients with known allergies to murine antibodies or other components of the formulation would have been at higher risk of allergic reactions.
* **Radiation Safety:**  Strict radiation safety protocols would have been followed during administration, handling, and disposal to minimize exposure to healthcare professionals and the patient.

### FAQs

* **Q: Why is this medication no longer available?** A:  Indium (In 111) imciromab pentetate was withdrawn from the market likely due to the development of more effective and safer diagnostic techniques for myocardial infarction, such as cardiac MRI and other nuclear medicine agents.  

* **Q: What are the alternatives for diagnosing a heart attack?** A:  Modern diagnostic tools for myocardial infarction include electrocardiograms (ECGs), blood tests (e.g., troponin levels), cardiac MRI, and other nuclear medicine techniques which are safer and provide more precise information.

* **Q: Is there any long-term risk from exposure to Indium-111?** A:  The radiation exposure from a properly administered dose of Indium-111 imciromab pentetate would have been carefully controlled and generally considered low risk. However, any concerns about long-term effects should be discussed with a medical professional.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The information provided here pertains to the historical use of this drug and should not be interpreted as a recommendation for its use.
